The first Eiger BioPharmaceuticals trade was made in Q2 2017. Since then Jim Simons bought shares thirteen more times and sold shares on nine occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in Eiger BioPharmaceuticals anymore.